Appointed
Jia-Bin Duh
Director
AXTI ·
AXT INC
the Board elected Jia-Bin Duh to the Board as a Class III Director and independent director, effective immediately.
Ready 8-Ks
50
Latest filing
July 30, 2026, 4:15 PM ET
Top materiality
0.85
Event mix
earnings ×20 · other_material ×16 · regulatory ×6
Sentiment
17 pos · 16 neg · 17 neu
Latest earnings
reported 2026-Q1
Executive change
recent →
Recent 8-K filings for AXTI
Highest-materiality recent filing
AXT Q1 revenue $19.4M, down 51% YoY; GAAP EPS loss $0.08
- Revenue $19.4M vs $39.7M Q1 2022; GAAP net loss $3.3M ($0.08/sh) vs income $3.2M ($0.07).
- GAAP operating loss $4.4M vs profit $3.7M YoY; gross margin 26.3% vs 33.6%.
-
AXT Q2 2026 revenue $47.6M, net income $11.1M; indium phosphide revenue record
Revenue $47.6M vs $26.9M Q1 2026 and $18.0M Q2 2025; GAAP net income $11.1M ($0.17 diluted EPS) vs net loss of $1.6M in Q1 2026.
-
AXT signs long-term InP supply agreement with Lumentum; receives $87M in deposits
6-year capacity reservation agreement for indium phosphide wafer substrates through Dec 31, 2031.
-
AXT reduces shareholder meeting quorum from majority to 33 1/3%
Board adopted bylaw amendment on July 26, 2026, effective immediately.
-
AXT appoints Jia-Bin Duh to board, expanding to six directors
Board expanded from 5 to 6; Duh elected as Class III independent director effective July 16, 2026.
-
AXT subsidiary Tongmei withdraws STAR Market IPO, triggers ~$49M redemption right for PE investors
On June 26, 2026, Tongmei withdrew its STAR Market IPO application; Shanghai Stock Exchange accepted on July 8, 2026.
-
AXT enters $22.3M prepaid supply deal with Coherent for 6-inch InP wafers
AXT subsidiary signs 3-year Master Development and Supply Agreement with Coherent for 6-inch InP wafer substrates.
-
AXT appoints Tracy Liu to Board as independent director; board expands to 5
Tracy Liu elected Class II independent director, effective June 17, 2026; board increased from 4 to 5.
-
AXT subsidiary signs $25.4M InP wafer supply deal with Casela for 2027
Tongmei, AXT's subsidiary, entered a Long-term Supply Agreement with Nanjing Casela Technologies for InP substrates.
-
AXT stockholders approve 71% increase in authorized common stock to 120M
Authorized common stock raised from 70M to 120M shares, effective June 4, 2026.
-
AXT adjourns 2026 annual meeting due to lack of quorum; reconvenes June 4, 2026
Only 48% of outstanding shares were represented at the May 14 meeting, failing quorum.
-
Revenue $26.9M, up 16.6% QoQ and 38.7% YoY; GAAP net loss narrows to $0.03/share.
-
AXT prices $550M public offering of 8.56M shares at $64.25; proceeds for InP capacity expansion
Public offering of 8,560,311 shares at $64.25/share for ~$550M gross; underwriters have 30-day option for up to 1,284,046 additional shares.
-
AXT pre-announces Q1 2026 revenue $26-28M, net loss $1.6-2.6M
Preliminary Q1 2026 revenue range $26-28 million, net loss $1.6-2.6 million.
-
AXT reports Q4 revenue down 18% QoQ; FY2025 net loss widens to $21.3M
Q4 revenue $23.0M, down 18% QoQ from $28.0M; GAAP EPS loss $0.08 vs $0.04 loss Q3.
-
AXT board declares LeBlanc independent, appoints him Audit Committee chair
Board re-evaluated Leonard J. LeBlanc's independence on Jan. 26, 2026, and found him independent under Nasdaq rules.
-
AXT revises Q4 2025 revenue to $22.5-23.5M on China export permit delays
Q4 2025 revenue expected $22.5-23.5M; fewer China export permits for indium phosphide than expected.
-
Underwriting agreement for 7,098,492 common shares at $12.25/share; gross proceeds ~$87M from base offering.
-
AXT reports Q3 revenue $28.0M, net loss $1.9M; indium phosphide up 250% QoQ
Revenue $28.0M vs $18.0M Q2'25 and $23.6M Q3'24.
-
AXT subsidiary receives China export permits for indium phosphide; expects millions in Q3 revenue
Beijing Tongmei Xtal Technology received export permits from China's Ministry of Commerce to resume shipping indium phosphide substrates.
-
AXT appoints Leonard J. Leblanc to Board to fill vacancy; Jesse Chen named Audit Committee Chair
Leonard J. Leblanc appointed as Class III director effective July 29, 2025, to fill vacancy from Christine Russell's passing.
-
AXT Q2 2025 revenue $18M, net loss $7M; GaAs export delays and China sluggishness
Revenue $18.0M, down 36% YoY from $27.9M; QoQ down from $19.4M.
-
AXT corrects 8-K to show Nasdaq notice date for audit committee non-compliance
Nasdaq notified AXT on July 18, 2025 that audit committee has only two independent directors after Christine Russell's passing.
-
Passing of director Christine Russell left Audit Committee with only two independent directors, violating Nasdaq Rule 5605(c)(2)(A).
-
AXT reports board director death; Audit Committee now non-compliant with Nasdaq rule
Christine Russell, independent director and Audit Committee Chair, passed away on July 11, 2025.
-
AXT cuts Q2 revenue guidance to $17.5-18M on export permit delays and weak China demand
Preliminary Q2 2025 revenue $17.5-18M, below prior guidance of $20-22M.
-
AXT subsidiary receives initial export permits for indium phosphide from China
Beijing Tongmei Xtal Technology, AXT subsidiary, received initial export permits from China's Ministry of Commerce.
-
AXT stockholders approve 2025 Equity Incentive Plan, elect director at annual meeting
Christine Russell elected Class III director with 94.9% of votes cast (14,621,153 For, 779,476 Withheld).
-
AXT Q1 2025 revenue $19.4M; GAAP gross margin -6.4%; net loss $0.20/share
Revenue $19.4M, down 23% sequentially from $25.1M and 15% YoY from $22.7M.
-
AXT reports FY2024 revenue up 31% to $99.4M; Q4 net loss of $5.1M widens sequentially
FY2024 revenue $99.4M (up 31% YoY); GAAP net loss $11.6M ($0.27/share) improves from $17.9M loss.
-
AXT Q3 revenue $23.6M, down sequentially; net loss $0.07/share, YoY improvement
Revenue $23.6M, -15% QoQ from $27.9M, +36% YoY from $17.4M.
-
AXT Q2 revenue $27.9M, up 50% YoY; net loss narrows to $0.04 per share
Revenue $27.9M, +23% sequential and +50% YoY; GAAP net loss $1.5M ($0.04/sh) vs $5.1M loss a year ago.
-
AXTI shareholders approve 3.6M share increase to equity plan; re-elect Jesse Chen
Stockholders approved amendment to 2015 Equity Incentive Plan to increase reserved shares by 3,600,000.
-
AXT Q1 revenue $22.7M, up 11% QoQ; IP substrates up 48%; net loss narrows
Revenue $22.7M, up 11% sequentially and 17% YoY; GAAP net loss ($2.1M) / ($0.05) vs ($3.6M)/$0.09 in Q4.
-
AXT pre-announces Q1 2024 revenue of $22.4-$22.7M, beating prior guidance
Preliminary Q1 2024 revenue expected $22.4M–$22.7M, above prior guidance of $20M–$22M.
-
AXT Q4 revenue $20.4M (+18% seq), net loss $0.09; FY revenue falls to $75.8M
Q4 2023 revenue $20.4M, up 18% from Q3 $17.4M, down 24% YoY from $26.8M.
-
AXT reports Q3 2023 revenue of $17.4M, net loss of $5.8M
Revenue $17.4M, down from $35.2M in Q3 2022 (YoY decline ~51%).
-
AXT Q2 revenue $18.6M, net loss $5.1M; gross margin slumps to 9.2%
Revenue $18.6M, down 53% YoY from $39.5M; GAAP net loss $5.1M ($0.12 EPS) vs. net income $5.5M YoY.
-
AXT addresses China's new export controls on gallium and germanium; to seek permits
China's new export regulations on gallium/germanium take effect Aug 1, 2023; AXT's China subsidiary will seek permits.
-
AXT shareholders elect Young and Chang as Class I directors at annual meeting
Dr. Morris S. Young re-elected with 26,094,280 shares for (94.5%); Dr. David C. Chang with 23,743,170 for (86.0%).
-
AXT Q1 revenue $19.4M, down 51% YoY; GAAP EPS loss $0.08
Revenue $19.4M vs $39.7M Q1 2022; GAAP net loss $3.3M ($0.08/sh) vs income $3.2M ($0.07).
-
AXT Q4 revenue $26.8M, down 29% YoY; GAAP EPS $0.03 vs $0.07 YoY
Q4 revenue $26.8M (-29% YoY); GAAP net income $1.3M ($0.03/share) vs $3.0M ($0.07) a year ago.
-
AXT Q3 2022: Revenue $35.2M, GAAP EPS $0.13, Indium Phosphide revenue up 12% QoQ
Revenue $35.2M, down 11% QoQ from $39.5M but up 2% YoY from $34.6M.
-
AXT cuts Q3 revenue guidance to $34-35M from $39-41M; cites China macro weakness
Preliminary Q3 revenue range of $34-35M, below prior guidance of $39-41M issued July 28, 2022.
-
AXT files 8-K/A correcting shareholder vote count for auditor ratification
Correction increases 'For' votes on Proposal 3 (BPM ratification) from 32,469,274 to 33,469,274.
-
AXT's subsidiary Tongmei revised IPO application accepted by CSRC for review
On August 1, 2022, CSRC accepted Tongmei's revised preliminary IPO application for review.
-
AXT Q2 2022 revenue $39.5M (+17% YoY); gross margin expands; STAR Market IPO approved
Revenue $39.5M, up 17% YoY from $33.7M; GAAP EPS $0.13 vs $0.10 YoY.
-
AXT subsidiary Tongmei receives SSE approval for STAR Market IPO; CSRC review remains
Shanghai Stock Exchange approved Tongmei's IPO listing application for the STAR Market.
-
AXT subsidiary Tongmei files updated IPO application; pre-announces H1 2022 revenue and profit range
Shanghai Stock Exchange accepted Tongmei's revised STAR Market IPO application for review on July 5, 2022.
-
On June 17, 2022, the Shanghai Stock Exchange accepted Tongmei's revised application for an IPO on the STAR Market.
-
AXT shareholders elect Christine Russell as Class III director, approve compensation and auditor
Christine Russell elected as Class III director with 94.4% of votes cast (26,022,373 for).
Executive changes
Appointed
Tracy Liu
Director
AXTI ·
AXT INC
Immediately thereafter, the Board elected Tracy Liu to the Board as a Class II Director and independent director, effective immediately.
Departed
Leonard J. LeBlanc
Director
AXTI ·
AXT INC
On December 29, 2021, Leonard J. LeBlanc, a member of the Board of Directors (the “Board”) of AXT, Inc (the “Company”) since April 2003 and a Class III director, notified the Board of his decision to resign from the Board and all committees thereof, effective as of December 29, 2021.
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.85 · Median 0.65 · Most common event earnings